Build your career on Magnet.me
Create a profile and receive smart job recommendations based on your liked jobs.
As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first and only medical device approved by the FDA for the treatment of long standing persistent Afib, our AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely used LAA management devices worldwide, and we are expanding into pain management therapies. We invest in innovation, clinical science, and education to focus on improving lives for our patients worldwide.
Position Summary:
The Regional Sales Manager, Cryo Nerve Block is responsible for prospecting, qualifying, and closing direct business sales in cardiac/thoracic operating and related departments within hospitals. This role must be able to train and support the surgeon and their staff in various procedures and provide support in the O.R. and during follow-up patient care as required. This position requires excellent relationship management, teamwork, and strategic planning.
What will you be doing:
A little about yourself:
What We Offer
With AtriCure, you'll get the opportunity to work with a team that is passionately dedicated to improving the lives of patients with Atrial Fibrillation worldwide. It is also a company that will invest in your professional development to help you grow and be successful in your role.
In addition, AtriCure also provides:
Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 150,000 implanted to date.
View what's on offer:
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.